Sahajanand Medical discloses insider trading regulation update
Sahajanand Medical discloses insider trading regulation update. The company filed an intimation under Regulation 8(2) of SEBI's Prohibition of Insider Trading Rules, 2015. This is a routine compliance disclosure with no financial impact. No material events or changes in shareholding were indicated.
📊 STOCKS: SMTL | 🏢 SECTOR: CapitalMarkets | #LOWIMPACT #InsiderTrading
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.